Epics Therapeutics
Latest round
- Seed
Last raised
- May 2018
Total raised
- $8.5M
Investors
- 5
About Epics Therapeutics
Founded in 2018 by Jean Combalbert and based in Belgium, Epics Therapeutics SA is a pharmaceutical discovery and development firm that develops small-molecule therapeutics that target RNA epigenetic pathways that contribute to cancer development. As of 2023, Franz Obermayr serves as the CEO of the company.W. The company's pipeline includes products that target RNA epigenetic modifications, a field that complements the system-wide epigenetic regulation of physiological processes. The firm is developing treatments based on RNA epigenetic target modulators, with the goal of translating RNA modification routes into the discovery of first-in-class medications in oncology and other disorders. Epics is also working to integrate its drug discovery and development platform and develop a robust pipeline of programs across the writer, eraser, and reader classes of RNA epigenetic targets to produce new medications for the treatment of human diseases.
Who invested in Epics Therapeutics
5 investors across 1 round
See all investors in Epics Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 24, 2018
Amount
$8.5M
Investors
Questions about Epics Therapeutics
Who invested in Epics Therapeutics?
Epics Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epics Therapeutics raised?
Epics Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Epics Therapeutics last raise money?
Epics Therapeutics's most recent round on record is a Seed, in May 2018.
What does Epics Therapeutics do?
Founded in 2018 by Jean Combalbert and based in Belgium, Epics Therapeutics SA is a pharmaceutical discovery and development firm that develops small-molecule therapeutics that target RNA epigenetic pathways that contribute to cancer development.
Where is Epics Therapeutics headquartered?
Epics Therapeutics is headquartered in Belgium.
Which VCs invest in companies like Epics Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Epics Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Epics Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.